SARS-CoV-2 Antibodies in Human Milk After mRNA and Adenovector-Based Vaccination: A Systematic Review and Meta-Analysis

Abstract

Background:

SARS-CoV-2 specific antibodies exist in human milk expressed by lactating parents after vaccination. In the existing research, the effects of vaccine types on human milk are inconsistent.

Research Aim:

This study aims to perform a systematic review and meta-analysis of the existing observational studies to compare the positive rates of SARS-CoV-2 specific antibodies in human milk according to mRNA and adenovector-based vaccination.

Methods:

PubMed, Web of Science, Elsevier Science Direct and Cochrane Library databases were systematically searched for relevant articles published from December 30, 2019 to February 15, 2023. Observational studies were considered eligible provided they reported data on SARS-CoV-2 specific antibodies in human milk. The risk of bias in non-randomized studies of interventions (ROBINS-I) tool, the Newcastle-Ottawa Scale (NOS), and the Agency for Healthcare Research and Quality (AHRQ) were used to assess risk of bias. Seven studies, including 511 lactating participants, were included in this review and meta-analysis.

Results:

The positive rate of SARS-CoV-2 IgA is higher in mRNA vaccine groups than in adenovector-based vaccine groups (OR = 4.80, 95% CI [3.04, 7.58], p < 0.001). The positive rate of SARS-CoV-2 IgG was higher in mRNA vaccines than in adenovector-based vaccines.

Conclusions:

Compared to adenovector-based vaccines, mRNA vaccines present a higher positivity rate of IgA and IgG in human milk after vaccination. In other words, mRNA vaccinations may offer breastfed children a higher level of protection than adenovector-based vaccinations. Further high-quality data is still required to substantiate these findings.

Keywords

adenovector-based vaccine antibody COVID-19 lactation Meta-analysis mRNA vaccine

Get full access to this article

View all access options for this article.

References

Albrecht

Arck

P. C.

(2020). Vertically transferred immunity in neonates: Mothers, mechanisms and mediators. Frontiers in Immunology, 11, Article 555. https://doi.org/10.3389/fimmu.2020.00555

Chen

M. J.

Cheema

Hoyt-Austin

Agnoli

Kuhn-Riordon

Kair

L. R.

(2023). Vaccination and treatment options for SARS-CoV2 infection affecting lactation and breastfeeding. Seminars in Fetal & Neonatal Medicine, 28(1), Article 101425. https://doi.org/10.1016/j.siny.2023.101425

Costa

Priolo

Fattore

Tedesco

Rubortone

S. A.

Giordano

Chioma

Neri

Lanzone

Buonsenso

Valentini

Vento

(2022). Rooming-in practice during the pandemic: Results from a retrospective cohort study. Journal of Human Lactation, 38(3), 443–451. https://doi.org/10.1177/08903344221081840

Henle

A. M.

(2023). Increase in SARS-CoV-2 RBD-Specific IgA and IgG antibodies in human milk from lactating women following the COVID-19 booster vaccination. Journal of Human Lactation, 39(1), 51–58. https://doi.org/10.1177/08903344221134631

United Nations Children’s Fund, World Health Organization, & the COVID-19 Infant Feeding Working Group. (2021). Frequently asked questions: COVID-19 vaccines and breastfeeding based on WHO interim recommendations. https://www.ennonline.net/breastfeedingandcovid19vaccines

Juncker

H. G.

Mulleners

S. J.

Ruhé

E. J. M.

Coenen

E. R. M.

Bakker

van Doesburg

Harinck

J. E.

Rood

R. D.

Bouhuijs

J. H.

Oomen

de Groot

Pajkrt

P. D.

Korosi

van Goudoever

P. J. B.

van Gils

M. J.

van Keulen

B. J.

(2022). Comparing the human milk antibody response after vaccination with four COVID-19 vaccines: A prospective, longitudinal cohort study in the Netherlands. EClinicalMedicine, 47, Article 101393. https://doi.org/10.1016/j.eclinm.2022.101393

Kantarcioglu

Iqbal

Lewis

Carter

C. A.

Singh

Lievano

Ligocki

Jeske

Adiguzel

Gerotziafas

G. T.

Fareed

(2022). An update on the status of vaccine development for SARS-CoV-2 including variants. Practical considerations for COVID-19 special populations. Clinical Applied Thrombosis Hemostasis, 2022 Jan-Dec;28:10760296211056648, https://doi.org/10.1177/10760296211056648

Lechosa-Muñiz

Paz-Zulueta

Irure-Ventura

Mendez-Legaza

J. M.

Cuesta González

Gómez-Acebo

López-Hoyos

Llorca

Cabero-Pérez

M. J.

(2023). Development of SARS-CoV-2 specific IgG and IgA antibodies in serum and milk with different SARS-COV-2 vaccines in lactating women. International Breastfeeding Journal, 18(1), 3. https://doi.org/10.1186/s13006-022-00536-y

Lechosa-Muñiz

Paz-Zulueta

Manuel Mendez-Legaza

Irure-Ventura

Cuesta Gonzalez

Calvo Montes

Lopez-Hoyos

Llorca

Jesus Cabero-Perez

(2021). Induction of SARS-CoV-2-Specific IgG and IgA in serum and milk with different SARS-CoV-2 vaccines in breastfeeding women: A cross-sectional study in Northern Spain. International Journal of Environmental Research and Public Health, 18(16), Article 8831. https://doi.org/10.3390/ijerph18168831

10.

Liberati

Altman

D. G.

Tetzlaff

Mulrow

Gøtzsche

P. C.

Ioannidis

J. P.

Clarke

Devereaux

P. J.

Kleijnen

Moher

(2009). The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration. PLoS Medicine, 6(7), Article e1000100. https://doi.org/10.1371/journal.pmed.1000100

11.

Mark

E. G.

Demirci

J. R.

Megli

Martin

J. M.

Rick

A. M.

(2023). Vaccination beliefs and attitudes of lactating people during the SARS-CoV-2 pandemic. Journal of Human Lactation, 39(3), 415–425. https://doi.org/10.1177/08903344231159640

12.

Matthew

J. P.

Joanne

E. M.

Patrick

M. B.

Isabelle

Tammy

C. H.

Cynthia

D. M.

Larissa

Jennifer

M. T.

Elie

A. A.

Sue

E. B.

Roger

Julie

Jeremy

M. G.

Asbjørn

Manoj

M. L.

Tianjing

Elizabeth

W. L.

Evan

M. W.

Steve

, . . .David

(2020). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. British Medical Journal, 372, Article n71. https://doi.org/10.1136/bmj.n71

13.

Mulleners

S. J.

Juncker

H. G.

van Gils

M. J.

van Goudoever

J. B.

van Keulen

B. J.

(2022). Human milk antibody response after combining two different COVID-19 vaccines: Mix-and-match. Journal of Human Lactation, 38(3), 401–406. https://doi.org/10.1177/08903344221103260

14.

Muyldermans

De Weerdt

De Brabandere

Maertens

Tommelein

(2022). The effects of COVID-19 vaccination on lactating women: A systematic review of the literature. Frontiers in Immunology, 13, 852928. https://doi.org/10.3389/fimmu.2022.852928.

15.

Oggero

M. K.

Wardell

D. W.

(2022). Changes in breastfeeding exclusivity and satisfaction during the COVID-19 pandemic. Journal of Human Lactation, 38(3), 433–442. https://doi.org/10.1177/08903344221086974

16.

Pieri

Maniori

M. A.

Shahabian

Kanaan

Paphiti-Demetriou

Pipis

Felekkis

Nicolaidou

Papaneophytou

(2022). Survival of vaccine-induced human milk SARS-CoV-2 IgG, IgA and SIgA immunoglobulins across simulated human infant gastrointestinal digestion. Nutrients, 14(16), Article 3368. https://doi.org/10.3390/nu14163368

17.

Scrimin

Campisciano

Comar

Ragazzon

Davanzo

Quadrifoglio

Giangreco

Stabile

Ricci

(2022). IgG and IgA antibodies post SARS-CoV-2 vaccine in the breast milk and sera of breastfeeding women. Vaccines, 10(1), 125. https://doi.org/10.3390/vaccines10010125

18.

Selma-Royo

Bauerl

Mena-Tudela

Aguilar-Camprubi

Perez-Cano

F. J.

Parra-Llorca

Lerin

Martinez-Costa

Carmen Collado

(2022). Anti-SARS-CoV-2 IgA and IgG in human milk after vaccination is dependent on vaccine type and previous SARS-CoV-2 exposure: A longitudinal study. Genome Medicine, 14(1), Article 42. https://doi.org/10.1186/s13073-022-01043-9

19.

Sterne

J. A. C.

Hernán

M. A.

McAleenan

Reeves

B. C.

Higgins

J. P. T.

(2021). Assessing risk of bias in a non-randomized study. In Higgins

J. P. T.

Thomas

Chandler

Cumpston

Page

M. J.

Welch

V. A.

(Eds.), Cochrane handbook for systematic reviews of interventions (Version 6.2; updated February 2021). Cochrane. http://www.training.cochrane.org/handbook

20.

Sterne

J. A. C.

Hernán

M. A.

Reeves

B. C.

Savović

Berkman

N. D.

Viswanathan

Henry

Altman

D. G.

Ansari

M. T.

Boutron

Carpenter

J. R.

Chan

A. W.

Churchill

Deeks

J. J.

Hróbjartsson

Kirkham

Jüni

Loke

Y. K.

Pigott

T. D.

, . . .Higgins

J. P. T.

(2016). ROBINS-I: A tool for assessing risk of bias in non-randomized studies of interventions. British Medical Journal, 355, Article i4919. https://doi.org/10.1136/bmj.i4919

21.

Ukoli

Leavell

Mayo

Moore

Nchami

Britt

(2023). Encouraging and reinforcing safe breastfeeding practices during the COVID-19 pandemic. International Journal Environmental Research and Public Health, 20(3), Article 1756. https://doi.org/10.3390/ijerph20031756

22.

Viswanathan

Ansari

M. T.

Berkman

N. D.

Chang

Hartling

McPheeters

Santaguida

P. L.

Shamliyan

Singh

Tsertsvadze

Treadwell

J. R.

(2008). Assessing the risk of bias of individual studies in systematic reviews of health care interventions. In: Methods guide for effectiveness and comparative effectiveness reviews. Agency for Healthcare Research and Quality (U.S.). https://www.ncbi.nlm.nih.gov/books/NBK91433/

23.

Wells

G. A.

Shea

O’Connell

Peterson

Welch

Losos

Tugwell

(2021). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. The Ottawa Hospital. https://www.ohri.ca//programs/clinical_epidemiology/oxford.asp

24.

Whited

Cervantes

(2022). Antibodies against SARS-CoV-2 in human breast milk after vaccination: A systematic review and meta-analysis. Breastfeeding Medicine, 17(6), 475–483. https://doi.org/10.1089/bfm.2021.0353

25.

World Health Organization Guidelines Approved by the Guidelines Review Committee. (2017). Guideline: Protecting, promoting and supporting breastfeeding in facilities providing maternity and newborn services. https://www.who.int/publications/i/item/9789241550086.

26.

World Health Organization. (2020). Frequently Asked Questions: Breastfeeding and COVID-19 for health care workers. https://www.who.int/publications/m/item/frequently-asked-questions-breastfeeding-and-covid-19

27.

World Health Organization. (2022). Coronavirus disease (COVID-19): Vaccines. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/coronavirus-disease-(covid-19)-vaccines

28.

World Health Organization. (2023). China: WHO Coronavirus Disease (COVID-19) Dashboard With Vaccination Data | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data. https://covid19.who.int/region/wpro/country/cn

29.

Yang

Fox

DeCarlo

Norris

Griffin

Wedekind

Flanagan

J. M.

Shenker

Powell

R. L.

(2022). Comparative profiles of SARS-CoV-2 spike-specific human milk antibodies elicited by mRNA- and adenovirus-based COVID-19 vaccines. Breastfeeding Medicine, 17(8), 638–646. https://doi.org/10.1089/bfm.2022.0019

30.

Zheng

Correa-Silva

Palmeira

Carneiro-Sampaio

(2022). Maternal vaccination as an additional approach to improve the protection of the nursling: Anti-infective properties of breast milk. Clinics, 77, Article 100093. https://doi.org/10.1016/j.clinsp.2022.100093

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.03 MB

0.02 MB